INTRODUCTION
Empyema thoracis has been recognised since the time of the Hippocrates but the optimal treatment remains controversial. [1] [2] [3] [4] [5] [6] As early as 1875, Gotthard Biilau advocated closed water seal drainage for empyema. 7 Berger et al, however, suggested that immediate drainage was not required for all patients with complicated parapneumonic effusions. 8 Fishman et al advised early decortication only in unusual circumstances, for example, in immunosuppressed patients and not as a primary treatment. 9 There is, thus, a tendency to persevere with antibiotics, thoracentesis, and closed intercostal tube drainage and a general reluctance to refer patients with empyema early for operative surgical management.
The present study is hence designed to evaluate evolving experience in the diagnosis and definitive management of empyema in an effort to identify factors contributing to morbidity.
METHODS

Study design
This study was a retrospective analysis of all adult cases of empyema thoracis admitted in the Cardiothoracic and Vascular surgery (CTVS) unit of Bir Hospital, a tertiary care teaching hospital in Kathmandu, Nepal over a period of 12 months (July 2009-June 2010).
Empyema thoracis was defined as pleural effusion with the presence of frank pus on pleural aspiration.
Exclusion criteria
(1) Age less than 16 years; (2) Empyema thoracis secondary to any surgical procedure.
Among forty-six consecutive patients, 38 were men and 8 women, with age range from 16 to 74 years. They were divided into two groups, one group (group 1, n = 29) consisted of patients who had undergone thoracotomy for decortication; and the other (group 2, n = 17) consisted of those who had undergone segmentectomy, lobectomy and redo-thoracotomy for pneumonectomy. The reason for segmentectomy, lobectomy and redo-thoracotomy were considered with respect to their duration of operation from the initial presentation. Data pertaining to mode of presentation, diagnosis, definitive management and complications (if any) were also analysed.
Ultrasound scan (USG) of the chest was performed and information concerning loculation, fluid density and thickness of the pyogenic membrane was documented. CT scan was performed in cases where an underlying disorder of the lung was suspected. The presence of loculated pleural fluid as shown by ultrasonogram or CT scan of the chest determined the need for thoracotomy.
The statistical signfcance was defined as p value <0.05. Analysis was carried out using MS Excel, SPSS software, version 11.5 (SOSS, Inc., Chicago, Illinois).
RESULT
The median duration of development of symptoms prior to surgery was 22 days (range 07-38 days, n=29) for the patients consisted of patients who had undergone thoracotomy for decortication (group 1) while the median duration of the development of symptoms prior to admission and operation was 42 days (range 18-90 days, n=17) for the patients who had undergone segmentectomy, lobectomy and redo-thoracotomy for pneumonectomy (group 2).
Fever, cough, chest pain and dyspnoea were the most common symptoms
In this study, Fourteen out of 17 (82.35%) of the patients who were initially treated with thoracocentesis or tube thoracostomy eventually required thoracotomy for segmentectomy, lobectomy and redo-thoracotomy for pneumonectomy. These included recurrent empyema with lung abscess (n = 3), restrictive lung disease (n = 3), bronchopleural fistula (n = 1) and scoliosis (n=1).
DISCUSSION
Empyema thoracis is defined as the presence of pus in the pleural cavity. Frank purulence must develop before an effusion is termed an empyema. The empyema may initially lie free in the pleural space but soon becomes encapsulated by fibrinous pleural adhesions. The pus becomes more viscous as fluid is absorbed. Fibrin is continually deposited on the pleural surfaces producing a thickened peel that can form as early as seven to 10 days after the onset of the parapneumonic effusion. 15 Adequate treatment at this stage usually allows full re-expansion of the lung with no functional impairment. The time of transition from acute to chronic empyema is arbitrary. Experimental animal models of empyema loculate within three days of bacterial invasion with fibroblast invasion evident at five days. 16 The free pleural fluid from the pleural space is easily drained before the deposition of intrapleural fibrin. As the empyema becomes chronic, however, continuing fibrosis promotes restriction of movement of the chest wall and diphragm leading eventually to a shrunken, immobile hemithorax with crowding of the ribs and scoliosis. Some permanent functional impairment follows even if lung re-expansion is achieved Considerable debate is therefore focused on the ideal management of empyema thoracis. Many authors suggest that the majority of patients with empyema can be adequately treated by tube drainage and antibiotics. 17 However, in our study, fourteen out of 17 (82.35%) of the patients who were initially treated with chest drainage required thoracotomy and for decortication.
Although this study was retrospective and nonrandomized, complications were clearly evident in patients in whom surgery was delayed. Empyema thoracis is a dynamic progressive condition that has been described in three pathological stages: exudative, fibropurulent and organized. 18 Large case-controlled studies are required to define the place of thoracoscopy in the definitive management of empyema. Given the limitations of all treatment modalities, prospective studies are required to develop evidence-based care pathways. In addition, prospective studies to define the effectiveness of open tube thoracostomy in different stage of empyema have to be conducted.
CONCLUSION
In our study, early thoracotomy and decortication was found to be an excellent surgical procedure. Functional results were also outstanding and the patients returned to normal activities that they have been performing before surgery. The post-operative results are also affected by the time duration between development of the symptoms and the time of surgery. Further prospective studies, should also be conducted to explore the benefits of tube tube thoracostomy in the early management of empyema thoracis and eliminate any confounding factors that might have existed.
